ASNSのチャート
ASNSの企業情報
| symbol | ASNS |
|---|---|
| 会社名 | Arsanis Inc （ア―サニス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Biological Products (No Diagnostic Substances) |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 アルザニス(Arsanis Inc.)は生物医薬品企業である。同社は重篤な感染の標的免疫療法用モノクローナル抗体（mAb）の発見・開発に焦点を当てる。同社のモノクローナル抗体は特定の病原体および病原性プロセスに重点を置く。製品パイプラインにはASN100、ASN200、ASN300、ASN400、およびASN500が含まれる。主導プログラムであるASN100は気道内に黄色ブドウ球菌が強く植菌された機械換気患者に、病院取得の黄色ブドウ球菌肺炎を予防するために研究される。ASN200は薬剤耐性の腸外大腸菌大腸菌感染症によって引き起こされる満たされていない医療ニーズに対応しています。 そのASN300は、カルバペネム耐性の肺炎桿菌感染の治療に使用される。ASN400は高齢者の死亡主要原因である肺炎連鎖球菌の治療に使用される。ASN500プログラムは呼吸器合胞体ウイルス（RSV）を標的とするmAbを含む。 ア―サニスは米国のバイオ医薬品企業。臨床段階で、重症感染症に対するモノクロ―ナル抗体免疫療法の開発に従事する。同社の製品候補には黄色ブドウ球菌肺炎予防のための「ASN100」が含まれる。また、呼吸器合胞体ウィルスを含む重篤な細菌病原体およびウィルス性病原体を標的とする免疫療法も開発する。本社所在地はマサチュ―セッツ州ウォルサム。 |
| 本社所在地 | 890 Winter Street Suite 230 Waltham MA 02451 USA |
| 代表者氏名 | Tillman U. Gerngross ティルマン・U・ゲーロングロス |
| 代表者役職名 | Co-Founder Chairman of the Board |
| 電話番号 | +1 781-819-5704 |
| 設立年月日 | 40391 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2017年 |
| 従業員数 | 40人 |
| url | www.arsanis.com |
| nasdaq_url | https://www.nasdaq.com/symbol/asns |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -47.99100 |
| 終値（lastsale） | 2.07 |
| 時価総額（marketcap） | 29632898.7 |
| 時価総額 | 時価総額（百万ドル） 27.91505 |
| 売上高 | 売上高（百万ドル） 0.00000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） -10.83295 |
| 当期純利益 | 当期純利益（百万ドル） -45.57400 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Arsanis Inc revenues was not reported. Net loss applicable to common stockholders increased from $11.1M to $22.8M. Higher net loss reflects Research and development - Balancing val increase from $8.2M to $16.4M (expense) General and administrative - Balancing v increase of 87% to $5.5M (expense) Stock-based Compensation in SGA increase from $230K to $1M (expense). |
ASNSのテクニカル分析
ASNSのニュース
Actelis Networks Announces 1.96M Share Offering by Selling Stockholders 2023/05/24 21:24:01 Investing.com
https://www.investing.com/news/assorted/actelis-networks-announces-196m-share-offering-by-selling-stockholders-432SI-3090281
Actelis Networks GAAP EPS of -$1.09, revenue of $1.85M 2023/05/12 14:30:14 Seeking Alpha
Actelis Networks press release (NASDAQ:ASNS): Q1 GAAP EPS of -$1.09.Revenue of $1.85M (-1.1% Y/Y).
Actelis Networks, Inc.: Actelis Networks Reports Fiscal First Quarter 2023 2023/05/12 12:36:00 Finanz Nachrichten
FREMONT, Calif., May 12, 2023 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid deployment networking solutions for wi…
Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday''s Mid-Day Session 2023/05/04 19:03:40 Benzinga
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB ) shares jumped 89.3% to $7.44. Actelis Networks, Inc. (NASDAQ: ASNS ) gained 68.7% to $6.04. Actelis Networks reported a $3.5 million private placement priced at-the-market under Nasdaq rules. Inseego Corp. (NASDAQ: INSG ) jumped 62% to $0.8789 after the company reported better-than-expected Q1 EPS and sales results. SaverOne 2014 Ltd (NASDAQ: SVRE ) gained 57% to $1.8099. The company announce the successful conclusion of a pilot demonstration with the Integrated Transport Centre, part of Abu Dhabi''s Ministry of Transport. Soligenix, Inc. (NASDAQ: SNGX ) surged 46% to $2.0790 after the company announced clinical results from a compatability study of HyBryte in the treatment of cutaneous T-cell lymphoma. Guardforce AI Co., Limited (NASDAQ: GFAI ) gained 34.7% to $6.86. Guardforce AI recently announced pricing of an $8 million underwritten public offering of ordinary shares. SigmaTron International, Inc. (NASDAQ: SGMA ) rose 29% to $3.09. SigmaTron International reported an agreement with its secured lenders and sale of a majority position of Wagz, Inc.
Why Are Actelis Networks Shares Trading Higher Today 2023/05/04 17:18:10 Benzinga
Actelis Networks, Inc (NASDAQ: ASNS ) shares traded upwards Thursday since it regained compliance with the Nasdaq. On May 3, Actelis Networks regained compliance with the minimum bid price requirement under Nasdaq for maintaining the listing of the shares Full story available on Benzinga.com
Actelis Networks GAAP EPS of -$0.17, revenue of $3.08M 2022/08/11 20:34:24 Seeking Alpha
Actelis Networks press release (NASDAQ:ASNS): Q2 GAAP EPS of -$0.17.Revenue of $3.08M (+1.7% Y/Y).
Actelis Networks Reports Second Quarter and First Half of Fiscal 2022 2022/08/11 20:05:00 GlobeNewswire
FREMONT, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid-deployment networking solutions for wide-area IoT networks, today reported financial results for the fiscal second quarter and first six months ended June 30, 2022.
Actelis Networks to Report Fiscal Second Quarter 2022 Financial Results on Thursday, August 11, 2022 at 4:30 p.m. ET 2022/08/03 20:30:00 GlobeNewswire
FREMONT, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid-deployment networking solutions for wide-area IoT networks, will hold a conference call on Thursday, August 11, 2022 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the fiscal second quarter ended June 30, 2022.